FentaGone aims to empowers individuals with the knowledge to make a potentially life-saving decision during an individual's most isolated and vulnerable moments through the use of innovative health technology.
FentaGone believes in the power of technology and innovation to create much needed change in critical sectors of health care. Integrating this innovative technology into the field of harm reduction we seek to spearhead new solutions to help tackle the opioid crisis impacting North America; helping to heal our nation and bring Canada to the forefront of technology in this field.
The opioid crisis is an international health epidemic causing detriment to both families and friendships. In Canada alone, there have been 17,602 apparent opioid toxicity deaths of which 21,824 are opioid-related and 9,869 stimulant-related poisonings resulting in hospitalizations nationwide from January 2016 to June 20201. Additionally, 94% of these opioid deaths are accidental1. Alberta, the homeplace of our team, is the second most affected province in Canada following closely behind British Columbia. This is often due to the contamination of illicit drugs with fentanyl; as on the street level, there is no public quality control of the products being administered. Compiling to an issue in which individuals are unaware of the potentially lethal contaminants within their substance.
FentaGone is a novel innovation that works to prevent street-level overdoses through the creation of a discreet and portable fentanyl detection system embedded within a simple syringe-like technology.
We seek to address the current gap that exists within the harm reduction field: a lack of effective street-level testing available to users. Annually, thousands of lives are lost, lives of members of society who are parents, siblings, and friends; who require greater innovation within the harm reduction field providing them access to life-saving technology.
A video courtesy of Ted-Ed exploring opioid addiction.
A video created by Kurzgesagt exploring the war on drugs.